bf/NASDAQ:FOLD_icon.jpeg

COM:AMICUSRX

Amicus Therapeutics

  • Stock

Last Close

9.59

21/11 21:00

Market Cap

3.06B

Beta: -

Volume Today

1.57M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.71M
-
4.02M
135.33%
6.51M
61.87%
11.22M
72.37%
16.80M
49.78%
23.19M
38.03%
25.32M
9.19%
41.76M
64.93%
average payables
5.50M
-
9.25M
68.24%
16.41M
77.50%
28.74M
75.14%
24.44M
14.98%
44.25M
81.06%
100.50M
127.14%
68.72M
31.62%
19.29M
71.93%
18.46M
4.28%
15.27M
17.31%
average receivables
1.99M
-
379.50K
80.95%
652K
-
5.38M
725.77%
15.71M
191.85%
27.62M
75.80%
40.10M
45.18%
49.80M
24.17%
59.43M
19.35%
76.91M
29.41%
book value per share
0.89
-
1.64
83.98%
3.16
92.80%
2.68
15.32%
2.30
14.14%
1.85
19.78%
1.98
7.36%
1.11
44.17%
1.13
2.36%
0.43
62.41%
542.66
127,379.81%
capex per share
-0.01
-
-0.00
76.41%
-0.04
1,270.69%
-0.04
1.04%
-0.03
33.35%
-0.03
15.04%
-0.08
145.16%
-0.01
85.02%
-0.01
14.79%
-0.01
8.95%
-25.21
193,369.73%
capex to depreciation
-0.40
-
-0.15
61.95%
-2.63
1,608.16%
-1.84
30.15%
-1.26
31.38%
-1.50
18.78%
-4.19
180.11%
-0.36
91.30%
-0.63
71.48%
-0.70
12.70%
-2.84
303.42%
capex to operating cash flow
0.02
-
0.00
69.65%
0.05
944.30%
0.04
17.82%
0.02
46.87%
0.02
0.12%
0.08
280.01%
0.01
82.69%
0.02
38.67%
0.02
17.87%
0.11
376.30%
capex to revenue
-1.91
-
-0.19
89.84%
-1.20
-
-0.12
89.79%
-0.07
43.59%
-0.11
58.84%
-0.01
88.74%
-0.01
2.78%
-0.01
10.02%
-0.02
62.87%
cash per share
1.60
-
2.04
27.43%
1.95
4.43%
2.46
26.24%
2.34
4.87%
2.71
16.06%
1.88
30.60%
1.87
0.86%
1.78
4.78%
1.02
42.86%
969.63
95,364.38%
days of inventory on hand
1.50K
-
270.59
81.92%
212.60
21.43%
233.35
9.76%
229.93
1.46%
284.01
23.52%
225.21
20.70%
583.75
159.20%
days payables outstanding
17.97K
-
460.46
97.44%
2.04K
343.69%
2.00K
2.08%
200.62
89.97%
227.83
13.56%
145.75
36.03%
147.85
1.44%
days sales outstanding
763.18
-
96.00
-
93.54
2.56%
87.85
6.08%
66.66
24.12%
65.65
1.52%
62.93
4.15%
73.39
16.62%
80.09
9.14%
debt to assets
0.11
-
0.07
39.76%
0.05
32.99%
0.15
225.89%
0.26
75.75%
0.41
55.27%
0.25
39.29%
0.50
101.52%
0.49
2.41%
0.62
28.40%
0.57
8.36%
debt to equity
0.32
-
0.12
62.87%
0.12
1.83%
0.43
259.26%
0.47
8.48%
0.94
101.29%
0.44
52.97%
1.54
249.56%
1.43
7.17%
3.67
156.60%
2.78
24.38%
dividend yield
earnings yield
-0.49
-
-0.11
77.51%
-0.12
11.34%
-0.30
141.69%
-0.13
57.03%
-0.20
52.36%
-0.15
22.38%
-0.05
69.57%
-0.08
72.49%
-0.07
16.10%
-36.19
53,894.69%
enterprise value
91.36M
-
609.65M
567.34%
1.04B
70.32%
635.41M
38.81%
2.32B
265.46%
2.02B
12.93%
2.41B
19.15%
6.26B
159.67%
3.33B
46.77%
3.83B
15.10%
202.25M
94.72%
enterprise value over ebitda
-1.52
-
-9.10
500.87%
-8.42
7.54%
-3.63
56.87%
-11.78
224.37%
-6.39
45.74%
-7.32
14.61%
-26.90
267.31%
-16.98
36.87%
-19.97
17.63%
-1.04
94.82%
ev to operating cash flow
-1.99
-
-11.80
491.46%
-10.37
12.12%
-4.22
59.29%
-10.78
155.31%
-6.74
37.45%
-9.62
42.72%
-26.82
178.74%
-16.44
38.68%
-23.01
39.92%
-2.93
87.28%
ev to sales
251.67
-
498.08
97.91%
128.16
-
62.88
50.94%
22.16
64.76%
13.22
40.34%
23.98
81.39%
10.90
54.55%
11.64
6.81%
0.51
95.65%
free cash flow per share
-0.91
-
-0.70
23.08%
-0.95
36.94%
-1.16
21.94%
-1.43
23.22%
-1.65
14.90%
-1.12
31.77%
-0.91
18.77%
-0.76
16.78%
-0.59
22.50%
-259.28
43,898.57%
free cash flow yield
-0.39
-
-0.08
78.27%
-0.10
17.46%
-0.23
138.00%
-0.10
57.44%
-0.17
72.59%
-0.12
32.89%
-0.04
65.74%
-0.07
66.37%
-0.05
26.69%
-18.27
37,759.24%
graham net net
0.01
-
0.86
5,712.13%
-3.15
467.33%
-2.56
18.89%
0.61
123.92%
0.42
31.55%
0.46
10.22%
-0.28
160.19%
-0.23
17.28%
-0.85
270.36%
-799.33
93,835.29%
graham number
4.83
-
5.85
21.04%
9.25
58.20%
9.47
2.41%
9.79
3.36%
8.83
9.80%
8.13
7.95%
5.16
36.54%
4.85
6.02%
2.80
42.26%
2.50K
89,339.54%
income quality
0.77
-
0.75
2.38%
0.76
1.11%
0.75
0.72%
0.76
0.83%
0.86
13.28%
0.70
18.25%
0.84
19.92%
0.81
4.06%
0.70
12.91%
0.46
35.27%
intangibles to total assets
0.27
-
0.16
39.25%
0.75
357.10%
0.66
12.39%
0.35
46.66%
0.28
20.62%
0.26
7.09%
0.25
4.10%
0.24
2.06%
0.30
24.99%
0.28
7.96%
interest coverage
-1.40K
-
-46.29
96.68%
-82.66
78.55%
-33.70
59.24%
-25.64
23.92%
-14.68
42.75%
-15.94
8.58%
-10.87
31.76%
-6.16
43.38%
-5.51
10.55%
1.54
127.96%
interest debt per share
0.28
-
0.21
24.87%
0.39
84.68%
1.19
203.34%
1.18
0.56%
1.85
56.32%
0.95
48.56%
1.79
88.16%
1.74
2.89%
1.69
2.80%
1.34K
78,949.20%
inventory turnover
0.24
-
1.35
453.17%
1.72
27.27%
1.56
8.89%
1.59
1.49%
1.29
19.04%
1.62
26.11%
0.63
61.42%
invested capital
0.32
-
0.12
62.87%
0.12
1.83%
0.43
259.26%
0.47
8.48%
0.94
101.29%
0.44
52.97%
1.54
249.56%
1.43
7.17%
3.67
156.60%
2.78
24.38%
market cap
120.52M
-
619.38M
413.91%
1.07B
72.15%
667.98M
37.35%
2.21B
230.37%
1.78B
19.35%
2.34B
31.57%
5.98B
155.25%
3.13B
47.55%
3.53B
12.58%
4.19M
99.88%
net current asset value
6.47M
-
66.79M
932.91%
-343.95M
614.99%
-336.63M
2.13%
117.79M
134.99%
104.06M
11.66%
146.29M
40.59%
-20.67M
114.13%
-937K
95.47%
-177.30M
18,822.52%
-134.65M
24.06%
net debt to ebitda
0.48
-
0.15
69.98%
0.23
55.67%
0.19
17.69%
-0.59
414.59%
-0.76
30.66%
-0.20
73.21%
-1.20
484.57%
-0.99
16.99%
-1.58
59.02%
-1.01
35.85%
net income per share
-1.16
-
-0.93
20.37%
-1.20
29.81%
-1.49
23.84%
-1.85
24.42%
-1.88
1.43%
-1.48
21.09%
-1.07
27.85%
-0.92
13.72%
-0.82
11.31%
-513.56
62,650.58%
operating cash flow per share
-0.89
-
-0.69
22.27%
-0.91
31.25%
-1.12
22.95%
-1.41
25.46%
-1.61
14.90%
-1.04
35.49%
-0.90
13.48%
-0.75
17.22%
-0.58
22.76%
-234.08
40,519.26%
payables turnover
0.02
-
0.79
3,802.30%
0.18
77.46%
0.18
2.13%
1.82
897.15%
1.60
11.94%
2.50
56.31%
2.47
1.42%
receivables turnover
0.48
-
3.80
-
3.90
2.63%
4.15
6.47%
5.48
31.78%
5.56
1.55%
5.80
4.32%
4.97
14.25%
4.56
8.37%
research and ddevelopement to revenue
115.55
-
38.91
66.33%
21.14
-
4.04
80.87%
2.97
26.57%
1.57
47.07%
1.18
24.76%
0.89
24.68%
0.84
5.63%
0.38
54.60%
return on tangible assets
-0.64
-
-0.39
38.73%
-0.59
50.13%
-0.57
3.79%
-0.70
23.14%
-0.61
12.29%
-0.57
7.66%
-0.42
26.55%
-0.37
11.99%
-0.47
28.41%
-0.27
42.36%
revenue per share
0.01
-
0.02
132.30%
0.04
-
0.24
552.80%
0.49
103.94%
0.76
54.34%
1.01
32.96%
1.13
11.69%
1.14
1.19%
1.35K
118,689.28%
roe
-1.30
-
-0.56
56.72%
-0.38
32.67%
-0.56
46.23%
-0.80
44.91%
-1.02
26.45%
-0.75
26.50%
-0.97
29.23%
-0.81
15.71%
-1.92
135.94%
-0.95
50.78%
roic
-1.01
-
-0.50
50.80%
-0.34
31.60%
-0.35
2.32%
-0.54
55.79%
-0.49
8.41%
-0.40
18.52%
-0.32
21.74%
-0.26
17.66%
-0.31
21.12%
-0.12
63.31%
sales general and administrative to revenue
52.05
-
16.93
67.48%
14.35
-
1.39
-
shareholders equity per share
0.89
-
1.64
83.98%
3.16
92.80%
2.68
15.32%
2.30
14.14%
1.85
19.78%
1.98
7.36%
1.11
44.17%
1.13
2.36%
0.43
62.41%
542.66
127,379.81%
stock based compensation to revenue
17.02
-
4.91
71.15%
3.53
-
0.63
82.28%
0.32
48.74%
0.24
23.97%
0.19
22.72%
0.19
0.48%
0.23
22.76%
0.22
7.25%
tangible asset value
11.14M
-
87.56M
686.18%
-336.66M
484.47%
-324.35M
3.66%
132.05M
140.71%
122.11M
7.53%
255.63M
109.33%
65.58M
74.34%
86.57M
32.00%
-97.75M
212.91%
-58.11M
40.55%
tangible book value per share
0.22
-
1.18
441.62%
-3.06
360.38%
-2.41
21.20%
0.86
135.68%
0.66
23.67%
1.06
61.77%
0.25
76.17%
0.32
25.90%
-0.34
206.02%
-196.88
58,120.63%
working capital
77.82M
-
134.39M
72.70%
142.99M
6.39%
229.10M
60.23%
321.93M
40.51%
464.97M
44.43%
391.26M
15.85%
449.79M
14.96%
450.86M
0.24%
284.80M
36.83%
315.37M
10.74%

All numbers in (except ratios and percentages)